4-chloroaniline | CAS:106-47-8

We serve 4-chloroaniline CAS:106-47-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-chloroaniline

Chemical Name:4-chloroaniline
CAS.NO:106-47-8
Synonyms:4-chloroaniline
1-Amino-4-chlorobenzene
4-Chlorobenzenamine
Benzenamine,4-chloro
P-CHLORANILINE
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 232.0±0.0 °C at 760 mmHg
Melting Point 67-70 °C(lit.)
Molecular Formula C6H6ClN
Molecular Weight 127.572
Flash Point 89.5±19.8 °C
Vapour density 4.4 (vs air)
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.598
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Phenacetin(CAS:62-44-2)、Chlordiazepoxide(CAS:58-25-3)、Diflubenzuron(CAS:35367-38-5)、Chlorbenzuron(CAS:57160-47-1)、Fluazuron(CAS:86811-58-7)、Anilofos(CAS:64249-01-0) and Inabenfide(CAS:82211-24-3).



Contact us for information like 4-chloroaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,P-CHLORANILINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,P-CHLORANILINE Use and application,4-chloroaniline technical grade,usp/ep/jp grade.


Related News: This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.5-methoxy-3,4-dihydro-1H-naphthalen-2-one manufacturer Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.3-Bromo-5-methylpicolinonitrile supplier Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.N-Ethyl-2,3-dioxopiperazine vendor Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.